$PKBK

PARKE BANCORP, INC. ANNOUNCES SECOND QUARTER 2026 EARNINGS

PARKE BANCORP, INC. (PKBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_970396.htm EXHIBIT 99.1 ex_970396.htm Exhibit 99.1 Parke Bancorp, Inc. 601 Delsea Drive, Washington Township, NJ 08080 Contact: Vito S. Pantilione, President and CEO Jonathan D. Hill, Senior Vice President and CFO (856) 256-2500 PARKE BANCORP, INC. ANNOUNCES SECOND Q

Original reporting
Published Jul 22, 2026, 12:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 22, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PKBK
Bullish
medium confidence
Mentioned
$PKBK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PKBKBullishMed
01

Why it matters

PKBK’s Q2 2026 earnings show net income up 47.8% YoY, net interest income up 28.8% YoY, and a lower credit-loss provision versus the prior-year quarter, with NIM unchanged at 4.17%.

02

Market read

Traders can update PKBK’s near-term earnings expectations and credit-risk read-through using the quantified NII, provision, and NIM figures disclosed in the filing.

03

What to watch

The excerpt does not include full asset-quality metrics (nonperforming assets, delinquency trends, allowance coverage) or guidance, which are key for assessing whether the provision decline reflects improving credit or timing effects.

Relevance 7/10Novelty 7/10Timing: after-hours earnings filing on July 22, 2026

Background

The filing is SEC Form 8-K, Item 2.02, with Exhibit 99.1 summarizing Parke Bancorp’s operating results for the three and six months ended June 30, 2026.

Company-level read

Ticker impact

$PKBKBullishMedium confidence
Context

Parke Bancorp reported Q2 2026 results, including net income of $12.2M, EPS $1.03 diluted, and NIM of 4.17% flat QoQ.

Expected impact

Moderately positive near-term bias as investors digest higher net income and lower credit-loss provision, assuming no adverse credit commentary beyond the provision figures.

Evidence & confidence

This is a primary earnings filing with multiple quantified line items (net income, net interest income, provision for credit losses, NIM). However, the excerpt is truncated before full balance-sheet/asset-quality detail, limiting conviction on credit risk trajectory.

Market effects

Adds another datapoint on small-bank profitability drivers (NIM stability, loan growth, and credit provision normalization) in a rate-sensitive environment.

Limited to local/regional banking sentiment unless asset-quality commentary indicates broader stress.

Low, as the filing is company-specific and not tied to systemic macro or cross-border events.

Counterpoint

Higher net interest income may be partly rate-driven and could reverse if market rates move against the bank’s asset-liability mix; provision decreases may not persist if charge-offs rise.

Key entities

  • Parke Bancorp, Inc.

    NASDAQ-listed parent company of Parke Bank; reported Q2 2026 operating results in an 8-K.

  • Parke Bank

    Operating bank under Parke Bancorp referenced as the company’s banking entity.

Related articles

$PKBKHigh

PARKE BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS

PARKE BANCORP, INC. (PKBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Parke Bancorp, Inc. 601 Delsea Drive, Washington Township, NJ 08080 Contact: Vito S. Pantilione, President and CEO Jonathan D. Hill, Senior Vice President and CFO (856) 256-2500 PARKE BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS Highlights: Net Income: $12.2 m

$EFXMedAI 8/10

UBS reiterates Buy on Equifax stock, keeps $220 price target

UBS maintained a Buy rating on Equifax (NYSE:EFX) with a $220 price target, citing strong Q3 earnings and an upbeat outlook. The stock is currently at $174.53, with InvestingPro valuing it at $228.97. Equifax's government business grew to $550M in annual contract value, and its records increased 12% YoY. Analysts have mixed views on its performance, with targets ranging from $175 to $217.

$NFLXMed

UBS cuts Netflix stock price target on softer guidance, content concerns

UBS cut Netflix's (NFLX) price target to $100 from $115, citing softer guidance and content concerns. Q3 revenue met expectations, but Q4 guidance was weaker due to one-time expenses. The stock is near its 52-week low, down 45% over the past year. Management expects 2026 revenue at the lower end of prior guidance, with advertising revenue reduced to $2.7B. Multiple analysts adjusted price targets, with ratings ranging from Buy to Overweight.

$TMOHighAI 9/10

Thermo Fisher Scientific Q3 Earnings Call Highlights

Thermo Fisher Scientific (TMO) reported Q3 revenue growth across most segments, with Life Sciences up 5%, Analytical Instruments up 6%, and Lab Products up 15%. Specialty Diagnostics saw a 6% revenue decline. Adjusted operating margins improved in all segments. The company introduced AI-enabled products and raised its 2026 revenue and EPS guidance to $47.7B-$48.2B and $25.13-$25.43, respectively. It also completed the divestiture of its microbiology business and repaid $1.1B in senior notes.